Controlling for Frailty in Pharmacoepidemiologic Studies of Older Adults-Reference-Cited by-同舟云学术

Controlling for Frailty in Pharmacoepidemiologic Studies of Older Adults

Published:2018-07 Issue:4 Volume:29 Page:556-561
ISSN:1044-3983
Container-title:Epidemiology
language:en
Short-container-title:

Author:

Cuthbertson Carmen C.,Kucharska-Newton Anna,Faurot Keturah R.,Stürmer Til,Jonsson Funk Michele,Palta Priya,Windham B. Gwen,Thai Sydney,Lund Jennifer L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Epidemiology

Reference26 articles.

1. Frailty in older adults: evidence for a phenotype.;Fried;J Gerontol A Biol Sci Med Sci,2001

2. Frailty: emergence and consequences in women aged 65 and older in the Women’s Health Initiative Observational Study.;Woods;J Am Geriatr Soc,2005

3. Phenotype of frailty: characterization in the women’s health and aging studies.;Bandeen-Roche;J Gerontol A Biol Sci Med Sci,2006

4. Operationalizing frailty in the Atherosclerosis Risk in Communities Study Cohort.;Kucharska-Newton;J Gerontol A Biol Sci Med Sci,2017

5. A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men.;Ensrud;J Am Geriatr Soc,2009

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unleashing frailty from laboratory into real world: A critical step toward frailty‐guided clinical care of older adults;Journal of the American Geriatrics Society;2024-08-21

2. Home Time Among Older Adults With Acute Myeloid Leukemia Following Chemotherapy;JAMA Oncology;2024-08-01

3. Longitudinal Changes in a Claims-Based Frailty Proxy Measure Compared to Concurrent Changes in the Fried Frailty Phenotype;The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences;2024-07-12

4. Assessing the Benefits and Harms of Pharmacotherapy in Older Adults with Frailty: Insights from Pharmacoepidemiologic Studies of Routine Health Care Data;Drugs & Aging;2024-07

5. Longitudinal trajectories of a claims-based frailty measure during adjuvant chemotherapy in women with stage I-III breast cancer;The Oncologist;2024-05-08